Effects of intrathecal ketorolac on human experimental pain

Anesthesiology

Volumn 112, Issue 5, 2010, Pages 1216-1224

  Eisenach, James C ^a   Curry, Regina ^b   Tong, Chuanyao ^b   Houle, Timothy T ^b   Yaksh, Tony L ^c  

^a Department of Anesthesiology and Physiology and Pharmacology ^*  (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; KETOROLAC; KETOROLAC TROMETAMOL; OXYHEMOGLOBIN; PROSTAGLANDIN E2;

ADULT; ALLODYNIA; ANXIETY DISORDER; ARTICLE; BLOOD PRESSURE; BURN; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DIZZINESS; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; FEMALE; HEADACHE; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERALGESIA; HYPERSENSITIVITY; LIMB WEAKNESS; MALE; MECHANICAL STIMULATION; NAUSEA; NOCICEPTIVE STIMULATION; NORMAL HUMAN; PAIN; PRIORITY JOURNAL; SENSITIZATION; SIDE EFFECT; THERMAL STIMULATION; ULTRAVIOLET B RADIATION;

ADOLESCENT; ADULT; CAPSAICIN; FEMALE; HOT TEMPERATURE; HUMANS; INJECTIONS, SPINAL; KETOROLAC; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PHYSICAL STIMULATION; ULTRAVIOLET RAYS; YOUNG ADULT;

EID: 77951667860     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181d94d8b     Document Type: Article

References (34)

1. Ramwell PW, Shaw JE, Jessup R: Spontaneous and evoked release of prostaglandins from frog spinal cord. Am J Physiol 1966; 211:998-1012
2. Yaksh TL: Central and peripheral mechanisms for the antialgesic action of acetylsalicylic acid, Acetylsalicylic Acid: New Uses for an Old Drug. Edited by Barnet JM, Hirsh J, Mustard JF. New York, Raven Press, 1982, pp 137-152
3. Malmberg AB, Yaksh TL: Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cy-clooxygenase inhibition. Science 1992; 257:1276-1279
4. Pellerin M, Hardy F, Abergel A: Chronic refractory pain in cancer patients: Value of the spinal injection of lysine acetylsalicylate. Presse Med 1987; 16:1465-1468
5. Yaksh TL, Horais KA, Tozier N, Rathbun M, Meschter C, Richter P, Rossi S, Tong C, Cline MJ, Eisenach JC: Intrathecal ketorolac in dogs and rats. Toxicol Sci 2004; 80: 322-334
6. Eisenach JC, Curry R, Hood DD, Yaksh TL: Phase I safety assessment of intrathecal ketorolac. Pain 2002; 99:599-604
7. Chizh BA, Priestley T, Rowbotham M, Schaffler K: Predicting therapeutic efficacy-Experimental pain in human subjects. Brain Res Rev 2009; 60:243-254
8. Eisenach JC, Hood DD, Curry R: Preliminary efficacy assessment of intrathecal injection of an American formulation of adenosine in humans. ANESTHESIOLOGY 2002; 96: 29-34 (Pubitemid 34032478)
9. Petersen KL, Rowbotham MC: A new human experimental pain model: The heat/capsaicin sensitization model. Neu-roreport 1999; 10:1511-1516
10. Eisenach JC, Yaksh TL: Safety in numbers: How do we study toxicity of spinal analgesics? ANESTHESIOLOGY 2002; 97:1047-1049
11. Yaksh TL, Rathbun ML, Provencher JC: Preclinical safety evaluation for spinal drugs, Spinal Drug Delivery. Edited by Yaksh TL. Amsterdam, Elsevier Science B.V., 1999, pp 417-437
12. Yaksh TL, Allen JW: The use of intrathecal midazolam in humans: A case study of process. Anesth Analg 2004; 98:1536-1545
13. Wang BC, Li D, Budzilovich G, Hiller JM, Rosenberg C, Hillman DE, Turndorf H: Antinociception without motor blockade after subarachnoid administration of S-(+)-ibu-profen in rats. Life Sci 1994; 54:715-720
14. Mazario J, Roza C, Herrero JF: The NSAID dexketoprofen trometamol is as potent as/n-opioids in the depression of wind-up and spinal cord nociceptive reflexes in normal rats. Brain Res 1999; 816:512-517
15. Malmberg AB, Yaksh TL: Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. ANESTHESIOLOGY 1993; 79:270-281
16. Bickel A, Dorfs S, Schmelz M, Forster C, Uhl W, Hand-werker HO: Effects of antihyperalgesic drugs on experimentally induced hyperalgesia in man. Pain 1998; 76: 317-325
17. 2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neuro-sci 2001; 21:5847-5853
18. Seidel K, Hamza M, Ates M, Guhring H: Flurbiprofen inhibits capsaicin induced calcitonin gene related peptide release from rat spinal cord via an endocannabinoid dependent mechanism. Neurosci Lett 2003; 338:99-102
19. Malmberg AB, Yaksh TL: Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 1992; 263:136-146
20. McCormack K, Kidd BL, Morris V: Assay of topically administered ibuprofen using a model of post-injury hyper-sensitivity. Eur J Clin Pharmacol 2000; 56:459-462
21. Schattschneider J, Buttel IZ, Binder A, Wasner G, Hed-derich J, Baron R: Mechanisms of adrenosensitivity in capsaicin induced hyperalgesia. Eur J Pain 2007; 11:756-763
22. Eisenach JC, Hood DD, Curry R: Relative potency of epi-dural to intrathecal clonidine differs between acute thermal pain and capsaicin-induced allodynia. Pain 2000; 84: 57-64
23. Eisenach JC, Curry R, Hood DD: Dose response of intrathecal adenosine in experimental pain and allodynia. ANESTHESIOLOGY 2002; 97:938-942
24. Eisenach JC, DuPen S, Dubois M, Miguel R, Allin D, Epi-dural Clonidine Study Group: Epidural clonidine analgesia for intractable cancer pain. Pain 1995; 61:391-399
25. Eisenach JC, Rauck RL, Curry R: Intrathecal, but not intravenous adenosine reduces allodynia in patients with neuropathic pain. Pain 2003; 105:65-70
26. Turnbach ME, Randich A: The effect of spinal and systemic administration of indomethacin on zymosan-induced edema, mechanical hyperalgesia, and thermal hyperalge-sia. J Pain 2001; 2:25-35
27. Vasquez E, Bär KJ, Ebersberger A, Klein B, Vanegas H, Schaible HG: Spinal prostaglandins are involved in the development but not the maintenance of inflammation-induced spinal hyperexcitability. J Neurosci 2001; 21:9001-9008
28. Bishop T, Hewson DW, Yip PK, Fahey MS, Dawbarn D, Young AR, McMahon SB: Characterisation of ultraviolet-B-induced inflammation as a model of hyperalgesia in the rat. Pain 2007; 131:70-82
29. Sycha T, Anzenhofer S, Lehr S, Schmetterer L, Chizh B, Eichler HG, Gustorff B: Rofecoxib attenuates both primary and secondary inflammatory hyperalgesia: A randomized, double blinded, placebo controlled crossover trial in the UV-B pain model. Pain 2005; 113:316-322
30. Gustorff B, Anzenhofer S, Sycha T, Lehr S, Kress HG: The sunburn pain model: The stability of primary and secondary hyperalgesia over 10 hours in a crossover setting. Anesth Analg 2004; 98:173-177
31. Bishop T, Ballard A, Holmes H, Young AR, McMahon SB: Ultraviolet-B induced inflammation of human skin: Characterisation and comparison with traditional models of hyperalgesia. Eur J Pain 2009; 13:524-532
32. Gordon SM, Brahim JS, Rowan J, Kent A, Dionne RA: Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: Replicate clinical trials in a tissue injury model. Clin Pharmacol Ther 2002; 72:175-183
33. Rice ASC, Lloyd J, Bullingham RES, O'Sullivan G: Ketorolac penetration into the cerebrospinal fluid of humans. J Clin Anesth 1993; 5:459-462
34. Buvanendran A, Kroin JS, Berger RA, Hallab NJ, Saha C, Negrescu C, Moric M, Caicedo MS, Tuman KJ: Upregula-tion of prostaglandin E2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans. ANESTHESIOLOGY 2006; 104:403-410